When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
UTHR - United Therapeutics GAAP EPS of $2.41 misses by $1.55 revenue of $466.9M beats by $5.84M
United Therapeutics Corporation
United Therapeutics press release ( NASDAQ: UTHR ): Q2 GAAP EPS of $2.41 misses by $1.55 .
Revenue of $466.9M (+4.6% Y/Y) beats by $5.84M .
“The recent approval and launch of Tyvaso DPI, coupled with the Medicare coverage decision for Tyvaso in PH-ILD, will provide additional momentum toward reaching our goal of 6,000 patients on Tyvaso by the end of the year.” said Michael Benkowitz, President and Chief Operating Officer of United Therapeutics.